CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,409,604 | -42.8% | 33,586 | -46.0% | 0.03% | -46.3% |
| Q4 2023 | $2,465,742 | +2.5% | 62,172 | -28.9% | 0.05% | -8.5% |
| Q3 2023 | $2,405,083 | -18.7% | 87,394 | +0.2% | 0.06% | -14.5% |
| Q2 2023 | $2,959,646 | +1.1% | 87,228 | +7.2% | 0.07% | -19.8% |
| Q1 2023 | $2,927,549 | -19.2% | 81,366 | +0.1% | 0.09% | -15.7% |
| Q4 2022 | $3,624,388 | +58.5% | 81,319 | -0.0% | 0.10% | +52.2% |
| Q3 2022 | $2,287,000 | +248.6% | 81,350 | +234.6% | 0.07% | +272.2% |
| Q2 2022 | $656,000 | -21.4% | 24,316 | -0.8% | 0.02% | -10.0% |
| Q1 2022 | $835,000 | -23.3% | 24,517 | -12.9% | 0.02% | -13.0% |
| Q4 2021 | $1,088,000 | – | 28,158 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |